Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030
Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide from drug–resistance infections. If solutions aren’t found and put in place, 10 million people could die from antibiotic resistance-related diseases by ... [Read]
Why Psychedelics Could Soon Replace Antidepressants
Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults each year, and despite the abundance of antianxiety medications available, treatment resistance occurs in roughly 30% of patients. Anxiety ... [Read]
Demand for Toad Venom Rises Along With the Booming Psychedelics Market
Depression and anxiety affect millions around the world and the venom of a toad is the latest psychedelic compound being used as an alternative treatment. The Sonoran desert toad is the only animal on earth ... [Read]
Pharmacy Giant Files Patent to Join the Metaverse
The Metaverse could soon have its own pharmacy after CVS revealed its plans to sell virtual goods and provide healthcare services in the virtual world. As CNBC reported on March 4, the pharmacy giant filed ... [Read]
Chronic Disease Increasing Need for Specialty Pharmacy Services
The average American’s lifespan may have increased to 78 years old, but chronic diseases are are still prevalent. According to the CDC, six in 10 adults in the US have a chronic disease and it ... [Read]
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of approval from Health Canada for medical purposes. Canada’s legislation now permits the use of psychedelics beyond palliative care, something health ... [Read]
CVS Stock Jumps On Plans to Expand a New Store Format
CVS stock is leading the healthcare sector higher after CVS Health Corp (NYSE:CVS) revealed a range of major new offerings at its stores. Expanding Strategy Access to quality healthcare is one of the most important ... [Read]
Johnson & Johnson Investigation: Shares Fall Again Over Asbestos
Another Johnson & Johnson investigation (NYSE:JNJ) is underway, and JNJ shares have taken a nosedive in response. Once again, the company is being investigated for asbestos contamination. JNJ shares dived from $136.39 USD to $134.55 USD ... [Read]
CVS Health Launches its Pilot Membership Program in Boston and Its Stock Jumps
CVS Health Corporation (NYSE:CVS), also known as CVS Pharmacy, just announced that customers in the Greater Boston area can enroll in CarePass. CarePass is CVS’s new pilot membership program that adds to its popular ExtraCare ... [Read]
Clovis Oncology Gets FDA Approval for Ovarian Cancer Treatment
Colorado-based biopharmaceutical company, Clovis Oncology (Nasdaq:CLVS) has received approval from the United States Food and Drug Administration (FDA) today for the company’s ovarian cancer maintenance treatment, RUBRACA (rucaparib). RUBRACA, which is available in the form ... [Read]